May 11 (Reuters) - Lombard Medical Inc EVAR.O
* Expects to achieve year-over-year revenue growth in 2016
of approximately 20 percent
* FDA approval and corresponding us launch of Intelliflex
remains on track for late 2016 or early 2017
* Lombard Medical reports 2016 first quarter financial
results
* Q1 revenue $2.9 million versus $3.4 million
* Q1 revenue view $3.6 million -- Thomson Reuters I/B/E/S
* Q1 loss per share $0.38
* Q1 earnings per share view $-0.41 -- Thomson Reuters
I/B/E/S
Source text for Eikon: ID:nGNXMRKHKa
Further company coverage: EVAR.O